Neuroinflammation and Disease: Pathways and Opportunities

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Neuroinflammation is increasingly recognized as a causative factor in neurodegenerative disorders.
• Neuroinflammation precedes symptom onset in Alzheimer's disease and is implicated in epilepsy and Parkinson's disease.

Purpose of the Study:

• To explore three emerging molecular pathways driving neuroinflammation: EP2 receptor, CCR2 receptor, and JAK/STAT signaling.
• To understand the convergence of these pathways and their role in sustaining chronic brain disease pathology.

Main Methods:

• Review and synthesis of current research on EP2 receptor, CCR2 receptor, and JAK/STAT signaling in neuroinflammation.
• Analysis of how these pathways modulate immune cell activation, recruitment, and cytokine amplification.

Main Results:

• The EP2 receptor (prostaglandin E2) modulates immune cell activation and exacerbates inflammation.
• The CCR2 receptor (chemokine CCL2) regulates peripheral immune cell recruitment to the brain.
• JAK/STAT pathways influence neuronal and glial function and can amplify or resolve neuroinflammation.

Conclusions:

• These three pathways converge on immune cell recruitment, cytokine amplification, and transcriptional regulation, creating feedforward loops in chronic brain diseases.
• Understanding these complex interactions provides opportunities for developing novel, disease-modifying therapeutic interventions for inflammatory neurological conditions.